Medicine and Dentistry
Breast Cancer
100%
Patient
65%
Cancer Stem Cell
56%
Metastatic Carcinoma
54%
Cells
41%
Cell Activity
39%
Tamoxifen
38%
Hormone Therapy
36%
Xenograft
32%
Neoplasm
27%
Bone
24%
Bone Metastasis
24%
Malignant Neoplasm
24%
Colony Formation
22%
Estrogen Receptor
22%
Cancer Cell
22%
Stem Cell
21%
Inpatient
20%
Tumor Xenograft
20%
Fulvestrant
20%
Dormancy
19%
Antiestrogen
18%
Therapeutic Procedure
18%
Breast Tumor
18%
Wnt Signaling
18%
Tumor Cell
14%
Gene
14%
Tumor Initiation
13%
Programmed Cell Death
12%
Sulforaphane
12%
Primary Culture
12%
Tumor Progression
12%
Bone Marrow
12%
Adjuvant Therapy
12%
Phosphorylation
10%
Organ
9%
Recurrent Disease
9%
K-Complex
9%
Tenidap
8%
Aptitude
8%
Aldehyde Dehydrogenase
8%
Estrogen Receptor Positive Breast Cancer
8%
Transplantation
7%
Lung
7%
In Vitro
6%
Mortality
6%
Salicylate Sodium
6%
Woman
6%
Breast Cancer Cell Line
6%
Ligase
6%
Biochemistry, Genetics and Molecular Biology
Sample
60%
Estrogen Receptor
58%
Cell Activity
50%
Dormancy
46%
Bile Acid
40%
Apoptosis
38%
Aldehyde Dehydrogenase
32%
Regulatory Mechanism
32%
Integrin
29%
Cancer Stem Cell
29%
Ectodomain
24%
P21-Activated Kinases
24%
STAT3
20%
Protein
19%
JAG1
18%
Bcl-2
15%
Galectin-3
14%
Catenin
14%
Cell Motility
14%
Colon
14%
Fulvestrant
14%
Tumor Initiation
13%
Electric Potential
13%
Aptitude
13%
Chenodeoxycholic Acid
12%
Sulforaphane
12%
Notch
12%
Mouse
11%
Nested Gene
10%
Colony Formation
10%
Degradation
9%
Amino Acid Transport
9%
Solution and Solubility
9%
Circular Dichroism
9%
Development
9%
Oxidative Stress
9%
Cell Membrane
9%
Cancer Cell
9%
K-Complex
9%
Promoter Region
9%
Upregulation
8%
Heat Shock
8%
Tumor Progression
7%
Deoxycholic Acid
7%
Lysozyme
7%
Membrane
7%
Mortality
6%
Self Concept
6%
Trichostatin A
6%
Gene Signature
6%
Pharmacology, Toxicology and Pharmaceutical Science
Butyrate
48%
Tamoxifen
32%
Breast Cancer
26%
Metastasis
24%
Estrogen Receptor
22%
Antiestrogen
18%
Malignant Neoplasm
17%
Apoptosis
15%
Fulvestrant
14%
Bile Acid
13%
Sulforaphane
12%
Colon Adenocarcinoma
10%
Prognosis
10%
Recurrent Disease
9%
Neoplasm
9%
Aldehyde Dehydrogenase
8%
Estrogen Receptor Positive Breast Cancer
8%
Tenidap
6%
Breast Tumor
6%
Estrogen Receptor Beta
6%
Receptor
6%